Corvus Pharmaceuticals
CRVS
CRVS
45 hedge funds and large institutions have $91M invested in Corvus Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
65% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 17
Holders
45
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.61M | |
| 2 | +$2.34M | |
| 3 | +$234K | |
| 4 |
Millennium Management
New York
|
+$219K |
| 5 |
Renaissance Technologies
New York
|
+$201K |
Top Sellers
| 1 | -$2.31M | |
| 2 | -$1.05M | |
| 3 | -$798K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$751K |
| 5 |
JP Morgan Chase
New York
|
-$393K |